Nordic ListingsIssuer Report
Ambu A/S: Quarterly Trading Report 2025 Q3
Ambu A/S: Quarterly Trading Report 2025 Q3https://view.news.eu.nasdaq.com/view?id=bf06f713e5b2c826249f3f95b41381dea&lang=en&src=omxlink
Ambu A/S: Quarterly Trading Report 2025 Q3
Earlier from Ambu A/s Class B
- AMBU_B: Ambitious strategy aims for global endoscopy leadership, 11%-13% CAGR, and 20%+ EBIT margin
- AMBU_B: Strong Q3 growth and raised guidance, despite FX and working capital headwinds
- Ambu A/S: Quarterly Trading Report 2024 Q4
- Ambu A/S: Quarterly Trading Report 2025 Q2